SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (8792)2/20/1999 7:59:00 PM
From: Tharos  Respond to of 17367
 
George,
Not specifically Xoma related, but I found it interesting.
* A Beginning, of Sorts, for Antisense - Profile of Isis and the
antisense saga
biomednet.com



To: aknahow who wrote (8792)2/20/1999 9:28:00 PM
From: Robert K.  Read Replies (2) | Respond to of 17367
 
bpi is not the only endotoxin mopper in play there. IMO.



To: aknahow who wrote (8792)2/21/1999 9:21:00 AM
From: Robert K.  Read Replies (1) | Respond to of 17367
 
Make no mistake,I believe the lbp morphed moleule is a addition to the bpi arsenal, not a replacement. Remember LBP potentiates bpi
killing something like 100 to 10,000 fold. And mening is a high lbp
condition, as are the other xoma indications (in general).
BUT WHAT IF you added a NON-stimulatory LBP to bpi
IN A NON high lbp disease state. HMMMMMMM......
and DuH........................


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News